Discover the Benefits of Early Stage Kinetic Characterization

Save time, work with suboptimal assay conditions and validate your ELISA data with the WAVEsystem.

Why this webinar?

The Creoptix^® WAVEsystem allows researchers to confidently detect and quantify biological interactions in real-time, for high-quality kinetic data across a broader range of samples than traditional equipment. During PEGS Boston - The Virtual Edition 2020 - our Senior Application Scientist Dr. Rony Nehmé’s discussed the benefits of early stage kinetic characterization with our WAVEsystem.

Get ahead in the race, catch the WAVE! with Dr. Rony Nehmé

• High-quality kinetics in a wide range of crude samples ranging from peptides to membrane proteins and relevant clinical samples.
• WAVE goodbye to lengthy and laborious receptor purification procedures.
• Welcome contaminants and work with crude samples.

Senior Application Scientist at Creoptix AG

Rony Nehmé, PhD

With over 10 years of experience in the membrane proteins field, Dr. Rony Nehmé has a deep and solid understanding of GPCRs biology, pharmacology and structural studies. He was an Investigator Scientist in the lab of Prof. Chris Tate (MRC-LMB in Cambridge) prior to joining Creoptix in 2018 as an Application Scientist. He holds a PhD in molecular biology from the Université de Nice-Sophia Antipolis in France.

Keeping Kinetics Real

• 

  Serology

  Real is (less)Diluted

• 

  Membrane Proteins

  Real is Native

• 

  Small Molecules

  Real is Crude

• 

  Biologics

  Real is Natural

• 

  COVID-19 Reserch

  Real is Relevant